Halozyme Therapeutics reported $446.97M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Amarin AMRN:US $ 327.02M 36.02M
Amgen AMGN:US $ 6630M 518M
Aptinyx Inc APTX:US $ 129.23M 17.58M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Baxter International BAX:US $ 3136M 46M
Cara Therapeutics CARA:US $ 22.33M 184K
Cytokinetics CYTK:US $ 37.15M 7.44M
Eli Lilly And LLY:US $ 3220M 217.6M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Halozyme Therapeutics HALO:US $ 446.97M 52.48M
Immunogen IMGN:US $ 239.54M 43.58M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
Intrexon XON:US $ 36.41M 9.06M
Mannkind MNKD:US $ 62.52M 185.31M
Minerva Neurosciences NERV:US $ 74.22M 5.92M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Peregrine Pharmaceuticals PPHM:US $ 159.69M 10.22M
Rigel Pharmaceuticals RIGL:US $ 84.82M 64.78M
United Therapeutics UTHR:US $ 942.2M 109.9M
Vanda Pharmaceuticals VNDA:US $ 57.24M 14.89M